Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Prandin, New Oral Treatment For Type II Diabetes, Now Available In The US PRINCETON, NJ -- June 8, 1998 -- Novo Nordisk Pharmaceuticals, Inc.’s Prandin(TM) (repaglinide) tablets, a new oral antidiabetic agent for treatment of type II diabetes, is now available in the United States. Prandin is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with type II diabetes mellitus whose hyperglycemia cannot be controlled satisfactorily by diet and exercise alone. It is also indicated for use in combination with metformin to lower blood glucose in patients who cannot be controlled by exercise, diet and Prandin or metformin alone, as the two products demonstrate a synergistic effect. Prandin has demonstrated a low incidence of severe hypoglycemia. In one-year controlled trials comparing Prandin with sulfonylureas for efficacy and safety, none of the Prandin-treated patients with symptomatic hypoglycemia developed coma or required hospitalisation. Prandin is available in 0.5 mg, 1 mg and 2 mg tablets. Studies are currently underway to evaluate Prandin in combination with other drugs. In the US, Prandin is co-promoted by Novo Nordisk Pharmaceuticals, Inc. and Schering-Plough Corp. Prandin was developed in co-operation with the German pharmaceutical company Boehringer Ingelheim. E-mail this page to a friend or colleague! To print, use this version